Showing results (1261-1270 of 1,708) with videos related to
Sort By:
Pageof 171
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.JAMA Network Open|July 9, 2020
Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI RegistryDavid W Biery, Adam N Berman, Avinainder Singh, et al.Journal of the American Heart Association|May 18, 2024
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.The American Journal of Medicine|October 18, 2017
Relationship of Hospital Teaching Status with In-Hospital Outcomes for ST-Segment Elevation Myocardial InfarctionTanush Gupta, Kavisha Patel, Dhaval Kolte, et al.JAMA Cardiology|May 12, 2017
Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve ReplacementSahil Khera, Dhaval Kolte, Tanush Gupta, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2024
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis PatientsChristina Charles-Schoeman, Roy Fleischmann, Eduardo Mysler, et al.Circulation. Cardiovascular Interventions|February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPIONBenjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.Diabetes, Obesity & Metabolism|February 25, 2020
Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trialHarpreet S Bajaj, Itamar Raz, Ofri Mosenzon, et al.Journal of the American College of Cardiology|October 16, 2020
Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve ReplacementSameer A Hirji, Edward D Percy, Siobhan McGurk, et al.Pageof 171